Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02165436 · ClinicalTrials.gov registry record · NA

Chewing Gum Facilitates an Earlier Return to Bowel Function in Pediatric Scoliosis Patients: A Prospective Randomized Study

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
83
Enrollment target

NCT02165436 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 83 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02165436, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
83 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the effectiveness of chewing gum on reducing post-operative ileus and reducing post-operative gastrointestinal symptoms in pediatric patients undergoing surgical correction of scoliosis. This study would provide minimal risk to its study population, and has the opportunity to provide a benefit to patients undergoing scoliosis surgery. If shown to be effective, this could lead to changes and improvement of the post-operative course for pediatric scoliosis patients.

Interventions

  • OTHER Control
  • OTHER Chewing gum

Trial Details

FieldValue
Enrollment Target 83 participants
Start Date 2009-07
Est. Completion 2013-07
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT02165436

The ClinicalTrials.gov registry entry for NCT02165436 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT02165436 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02165436 about?

NCT02165436 is a clinical study titled "Chewing Gum Facilitates an Earlier Return to Bowel Function in Pediatric Scoliosis Patients: A Prospective Randomized Study". The purpose of this study is to evaluate the effectiveness of chewing gum on reducing post-operative ileus and reducing post-operative gastrointestinal symptoms in pediatric patients undergoing surgical correction of scoliosis. This study would provide minimal risk to its study population, and has t...

What is the current status of trial NCT02165436?

This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2009-07. Estimated completion is 2013-07.

What interventions are being tested in trial NCT02165436?

The interventions under investigation include: Control (OTHER), Chewing gum (OTHER).

Who is sponsoring clinical trial NCT02165436?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.